Showing entries 1 to 3 of 54
Continued support over Xmas and New Year for Action Duchenne.
Meeting on the 4th & 5th December in Belfast and update of Care Advisor.
UK drug discovery company, is pleased to announce that the United States Food & Drug Administration ('the US FDA') has granted orphan drug status to the clinical candidate SMT C1100.